Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$4,621,367
+$522,768 QoQ
Shares Held
18,365
-2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#1,365
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PLIMOTH TRUST CO LLC holds $39,896,675 across 10 Drug Manufacturers - General names. ABBV ranks #4 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,201 | $11,035,955 | |
| 2 | MRK |
Merck & Co., Inc.
|
63,317 | $8,136,234 | |
| 3 | JNJ |
Johnson & Johnson
|
30,772 | $7,815,164 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
18,365 | $4,621,367 | |
| 5 | AMGN |
Amgen Inc
|
11,650 | $4,218,697 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,547 | $1,414,398 | |
| 7 | PFE |
Pfizer Inc
|
49,223 | $1,185,289 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,575 | $830,685 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,621,367 | 18,365 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $4,098,599 | 18,845 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,411,456 | 19,307 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $4,518,965 | 19,517 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $3,724,465 | 20,065 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,247,598 | 20,273 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $3,606,421 | 20,295 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,060,188 | 20,560 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $3,711,863 | 21,641 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $4,790,140 | 26,305 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $4,384,410 | 28,292 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $4,295,312 | 28,816 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $3,940,852 | 29,250 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $4,641,013 | 29,121 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $4,591,178 | 28,409 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $3,959,328 | 29,501 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $4,510,101 | 29,447 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $4,988,935 | 30,775 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $4,198,753 | 31,010 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $3,286,043 | 30,463 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $3,315,106 | 29,431 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $3,358,715 | 31,036 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $3,203,676 | 29,899 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $2,661,947 | 30,391 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $3,080,396 | 31,375 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,455,222 | 32,225 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||